(Q86075893)
Statements
Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer (English)
Marco Montanari
Ermanno Rondini
Giovanni Luca Frassineti
Rodolfo Mattioli
Silvia Carloni
Wainer Zoli
Dino Amadori
Giorgio Cruciani
1 November 2012